Desk› Healthcare› Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd

BSE 533573 APLLTD INE901L01018

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 30 trading days

17 filings · 9 material · busiest 2026-08-04

What it files

Newspaper Publication3 Press Release3 KMP2 AGM / EGM2 Analyst / Investor Meet2 Concall Transcript1 Board Outcome1 Results1

Filings

17 in the window

25 August 2026

Newspaper Publication

Newspaper Publication

Please find attached.

Company Update / Newspaper Publication View filing →
20 August 2026

KMP

Appointment of Company Secretary and Compliance Officer

Intimation regarding Appointment of Company Secretary of the Company.

Company Update / Appointment of Company Secretary / Compliance Officer View filing →
11 August 2026

Newspaper Publication

Newspaper Publication

Please find attached.

Company Update / Newspaper Publication View filing →
10 August 2026

Concall Transcript

Earnings Call Transcript

Please find attached herewith the Transcript of Post Result Conference Call held on 4th August, 2026.

Company Update / Earnings Call Transcript View filing →
10 August 2026

KMP

Resignation of Company Secretary / Compliance Officer

Please find attached.

Company Update / Resignation of Company Secretary / Compliance Officer View filing →
6 August 2026

AGM / EGM

Shareholder Meeting / Postal Ballot-Scrutinizer's Report

Please find attached herewith the Scrutinizer Report and Voting Results of the AGM held on 5th August, 2026.

AGM/EGM / AGM View filing →
5 August 2026

Newspaper Publication

Newspaper Publication

Please find attached herewith the Newspaper Advertisement.

Company Update / Newspaper Publication View filing →
5 August 2026

AGM / EGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

Please find attached Proceedings of AGM held on 5th August, 2026.

AGM/EGM / AGM View filing →
4 August 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting

Please find enclosed herewith Outcome of Board Meeting.

Board Meeting / Outcome of Board Meeting View filing →
4 August 2026

Results

Unaudited Financial Results For The Quarter Ended June 30, 2026

Please find attached Unaudited Financial Results for the Quarter ended 30th June, 2026.

Result / Financial Results View filing →
4 August 2026

Investor Presentation

Investor Presentation

Please find attached Investor Presentation.

Company Update / Investor Presentation View filing →
4 August 2026

Press Release

Press Release / Media Release

Please find attached Press Release on Unaudited Financial Results for the quarter ended 30th June, 2026.

Company Update / Press Release / Media Release View filing →
4 August 2026

Press Release

Press Release / Media Release (Revised)

Please find attached Revised Press Release on Unaudited Financial Results for the quarter ended 30th June, 2026.

Company Update / Press Release / Media Release (Revised) View filing →
4 August 2026

Analyst / Investor Meet

Analyst / Investor Meet - Outcome

Please find attached audio recording of investor call.

Company Update / Analyst / Investor Meet View filing →
28 July 2026

Press Release

Press Release / Media Release

Alembic Pharmaceuticals Limited receives USFDA Final approval for Prucalopride Tablets, 1 mg and 2 mg.

Company Update / Press Release / Media Release View filing →
27 July 2026

Analyst / Investor Meet

Analyst / Investor Meet - Intimation

Please find attached herewith Intimation for Investors Call Scheduled to be held on 4th August, 2026.

Company Update / Analyst / Investor Meet View filing →
24 July 2026

Board Meeting

Board Meeting Intimation for Board Meeting To Consider Unaudited Financial Results For The Quarter Ended 30Th June, 2026.

Alembic Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve Unaudited Financial ....

Board Meeting / Board Meeting View filing →